An interventional study of PRP Injection and Corticosteroid Injection in Pain, sponsored by Zimmer Biomet. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-19.
Sponsored by Zimmer Biomet · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Pain with a site in Netherlands — 10 open to participants now, 13 under way, 1 of them phase 3. Pain · Netherlands.
Among the 106 studies in Pain with a site in Netherlands, this one is the 36th largest by enrollment of the 86 interventional ones that give a count, is one of 5 that started in 2007, is one of 43 with no phase, and was the 18th registered.
10,069 studies on the registry are indexed under Pain; 1,650 are open to participants now.
Browse Pain studies →10 of the 106 studies in Pain with a site in Netherlands are open now. Recruiting first, the newest first:
Leiden University Medical Center · Sites in Netherlands
Ages 18+
Radboud University Medical Center · Sites in Netherlands
Ages 17+ · Women only · Healthy volunteers
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Sites in Netherlands
Ages 6–18
Dijklander Ziekenhuis · Sites in Netherlands
Ages 35–90
Erasmus Medical Center · Sites in Netherlands
Ages 18–110
A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →
Of the 927 Pain studies recruiting now, 382 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 221 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 14 · Phase 3 20 · Phase 4 5
First in 2003; this study’s year is marked. 5 started in 2007.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 106 is above the median of 66 across 8,505 interventional studies indexed under Pain.
Median enrollment 85 across the 86 interventional studies, 102 across the 20 observational. Of the 83 that completed or were terminated, 14 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
35 of 106 have an industry lead sponsor. The 10 most frequent:
Zimmer Biomet is the lead sponsor of 275 studies on the registry; 28 are open to participants now.
Of its 22 completed or terminated interventional studies of FDA-regulated products, 19 (86%) have results posted.
Zimmer Biomet has 7 studies filed under Pain — fewer than ten, so there is no comparison to draw.
2 of the studies in Pain with a site in Netherlands that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07629661Erasmus Medical CenterEffectiveness and Implementation of a Clinical Pain Management Dashboard for the NICU | 2026-11-30 |
| NCT06332560Radboud University Medical CenterPain in Endometriosis And the Relation to Lifestyle | 2027-05 |
Add all 2 to your calendar (.ics) → With an account.
Among the 106 studies in Pain with a site in Netherlands, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study is to compare the efficacy of autologous platelet concentrate injections to corticosteroid injection in patients suffering from tennis elbow with respect to pain and function.
Patients with chronic plantar fasciitis will be allocated randomly to have a steroid injection or an autologous platelet concentrate injections. Data will be collected before the procedure, 4, 8, 12, 26 weeks and 1 year after the procedure. The main outcome measures of this study are pain and function measured with questionnaires.
Exclusion Criteria:
PRP injection
Biological: PRP Injection
Corticosteroid Injection
Biological: Corticosteroid Injection
PRP Injection
Corticosteroid Injection
Visual Analog Score - Pain
Time frame: 4months,12 months,24months & 52 months
DASH
Time frame: 4months,12months,24months & 52 months
Complications
Time frame: Anytime
Plan to share: No
No publications or documents are linked to this record.
The record gives a start of Aug 2007, a primary completion of Jan 2008 and a completion of Jan 2009. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Platelet rich plasma